The different onset time of ARDS can bring about protein biomarker diversity, such as receptor for advanced glycation end product (RAGE)s and Angiopoietin (Ang)-2, markers of alveolar capillary barrier injury, which are only elevated in early-onset ARDS (36). The gene discussed is AGER; the disease is acute respiratory distress syndrome.